The impact of visit-to-visit systolic blood pressure variability on residual renal function and left ventricular hypertrophy in peritoneal dialysis patients

The impact of visit-to-visit systolic blood pressure variability on residual renal function and left ventricular hypertrophy in peritoneal dialysis patients

Background/aim: Blood pressure (BP) variability is more closely associated with adverse outcomes than ‘usual’ BP in the generalpopulation. Residual renal function (RRF) and left ventricular hypertrophy (LVH) are thought to be predictors of poor outcome indialysis patients. However, only a few studies have focused on BP variation and its link to RRF, LVH, and outcome in peritoneal dialysis(PD) patients. Therefore, we aimed to explore the effect of visit-to-visit BP variability on RRF and LVH in continuous ambulatory PD(CAPD) patients.Materials and methods: We performed an observational study that included all prevalent PD patients between 1 February 2006 and 31January 2007. All patients underwent BP measurements, pulse wave velocity (PWV), cardiac ultrasound, and biochemical examinationduring the 1-year observation. Patients were divided into the HBPV group (higher BP variability) and LBPV group (lower BP variability)based on the standard deviation of systolic BP (SBP).Results: There were 70 patients recruited for the final analysis. Patients with HBPV had a higher SBP as compared to patients with LBPVat baseline. Renal Kt/V decreased significantly from 0.50 ± 0.49 to 0.32 ± 0.35 (P < 0.01) in HBPV group (but not in the LBPV group)during follow-up. Patients with HBPV also showed a higher left ventricular mass index (LVMI) and PWV than those with LBPV at theend of follow-up.Conclusion: Our study suggests that BP variability may affect RRF in PD patients. PD patients with HBPV had a faster decline in RRFand higher PWV and LVH.

___

  • Sharma R, Pellerin D, Brecker SJ. Cardiovascular disease in end stage renal disease. Minerva Urol Nefrol 2006; 58: 117-131.
  • Chang TI. Systolic blood pressure and mortality in patients on hemodialysis. Curr Hypertens Rep 2011; 13: 362-369.
  • Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlof B, Sever PS, Poulter NR. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375: 895-905.
  • Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010; 375: 938-948.
  • Selvarajah V, Pasea L, Ojha S, Wilkinson IB, Tomlinson LA. Pre-dialysis systolic blood pressure-variability is independently associated with all-cause mortality in incident haemodialysis patients. PloS One 2014; 9: e86514.
  • Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension 2011; 57: 160-166.
  • Di Iorio B, Pota A, Sirico ML, Torraca S, Di Micco L, Rubino R, Guastaferro P, Bellasi A. Blood pressure variability and outcomes in chronic kidney disease. Nephrol Dial Transpl 2012; 27: 4404-4410.
  • Mallamaci F, Minutolo R, Leonardis D, D’Arrigo G, Tripepi G, Rapisarda F, Cicchetti T, Maimone I, Enia G, Postorino M et al. Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. Kidney Int 2013; 84: 381- 389.
  • Chang TI, Flythe JE, Brunelli SM, Muntner P, Greene T, Cheung AK, Chertow GM. Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis. J Hum Hypertens 2014; 28: 18-24.
  • Flythe JE, Brunelli SM. Blood pressure variability and dialysis: variability may not always be the spice of life. J Am Soc Nephrol 2014; 25: 650-653.
  • Di Iorio B, Di Micco L, Torraca S, Sirico ML, Guastaferro P, Chiuchiolo L, Nigro F, De Blasio A, Romano P, Pota A et al. Variability of blood pressure in dialysis patients: a new marker of cardiovascular risk. J Nephrol 2013; 26: 173-182.
  • Flythe JE, Inrig JK, Shafi T, Chang TI, Cape K, Dinesh K, Kunaparaju S, Brunelli SM. Association of intradialytic blood pressure variability with increased all-cause and cardiovascular mortality in patients treated with long-term hemodialysis. Am J Kidney Dis 2013; 61: 966-974.
  • Rossignol P, Cridlig J, Lehert P, Kessler M, Zannad F. Visitto-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: insights from FOSIDIAL. Hypertension 2012; 60: 339-346.
  • Flythe JE, Brunelli SM. Blood pressure variability among chronic dialysis patients: recent advances in knowledge. Curr Opin Nephrol Hy 2015; 24: 163-169.
  • Atas N, Erten Y, Okyay GU, Inal S, Topal S, Onec K, Akyel A, Çelik B, Tavil Y, Bali M et al. Left ventricular hypertrophy and blood pressure control in automated and continuous ambulatory peritoneal dialysis patients. Ther Apher Dial 2014; 18: 297-304.
  • Jo HA, An JN, Lee JP, Oh KH, Lim CS, Oh YK. Visit-to-visit variability in systolic blood pressure is a risk factor for rapid loss of residual renal function in peritoneal dialysis patients. Tohoku J Exp Med 2015; 235: 295-304.
  • Shigenaga A, Tamura K, Dejima T, Ozawa M, Wakui H, Masuda S, Azuma K, Tsurumi-Ikeya Y, Mitsuhashi H, Okano Y et al. Effects of angiotensin II type 1 receptor blocker on blood pressure variability and cardiovascular remodeling in hypertensive patients on chronic peritoneal dialysis. Nephron Clin Pract 2009; 112: 31-40.
  • Nongnuch A, Assanatham M, Panorchan K, Davenport A. Strategies for preserving residual renal function in peritoneal dialysis patients. Clinical Kidney Journal 2015; 8: 202-211.
  • Rocco M, Soucie JM, Pastan S, McClellan WM. Peritoneal dialysis adequacy and risk of death. Kidney Int 2000; 58: 446-457.
  • Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S, Mexican Nephrology Collaborative Study Group. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13: 1307-1320.
  • Yokota K, Fukuda M, Matsui Y, Hoshide S, Shimada K, Kario K. Impact of visit-to-visit variability of blood pressure on deterioration of renal function in patients with non-diabetic chronic kidney disease. Hypertens Res 2013; 36: 151-157.
  • Whittle J, Lynch AI, Tanner RM, Simpson LM, Davis BR, Rahman M, Whelton PK, Oparil S, Muntner P. Visit-tovisit variability of BP and CKD outcomes: results from the ALLHAT. Clin J Am Soc Nephro 2016; 11: 471-480.
  • Hassan AKM, Abd-El Rahman H, Mohsen K, Dimitry SR. Impact of in-hospital blood pressure variability on cardiovascular outcomes in patients with acute coronary syndrome. J Clin Hypertens 2017; 19: 1252-1259.
  • Nolph KD, Moore HL, Prowant B, Meyer M, Twardowski ZJ, Khanna R, Ponferrada L, Keshaviah P. Cross sectional assessment of weekly urea and creatinine clearances and indices of nutrition in continuous ambulatory peritoneal dialysis patients. Periton Dialysis Int 1993; 13: 178-183.
  • Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33: 27-39.
  • Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
  • Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
  • Savage DD, Garrison RJ, Kannel WB, Levy D, Anderson SJ, Stokes J 3rd, Feinleib M, Castelli WP. The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study. Circulation 1987; 75: 26-33.
  • Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, Target R, Levy BI. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995; 26: 485-490.
  • Mallamaci F, Tripepi G. Blood pressure variability in chronic kidney disease patients. Blood Purificat 2013; 36: 58-62.
  • Yokota K, Fukuda M, Matsui Y, Kario K, Kimura K. Visit-tovisit variability of blood pressure and renal function decline in patients with diabetic chronic kidney disease. J Clin Hypertens 2014; 16: 362-366.
  • Okada H, Fukui M, Tanaka M, Inada S, Mineoka Y, Nakanishi N, Senmaru T, Sakabe K, Ushigome E, Asano M et al. Visitto-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. Atherosclerosis 2012; 220: 155-159.
  • Mancia G, Parati G. The role of blood pressure variability in end-organ damage. J Hypertens 2003; 21: 17-23.
  • Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 2010; 375: 906-915.